TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Substitutes 17
Rivalry 18
LEADING COMPANIES 19
Boehringer Ingelheim 19
MediGene AG 23
Merck KGaA 27
Morphosys 30
MARKET FORECASTS 34
Market value forecast 34
MACROECONOMIC INDICATORS 35
APPENDIX 37
Methodology 37
Industry associations 38
Related Datamonitor research 38
Disclaimer 39
ABOUT DATAMONITOR 40
Premium Reports 40
Summary Reports 40
Datamonitor consulting 40
LIST OF TABLES
Table 1: Germany biotechnology market value: $ million, 2006–10 10
Table 2: Germany biotechnology market segmentation I:% share, by value, 2010 11
Table 3: Germany biotechnology market segmentation II: % share, by value, 2010 12
Table 4: Boehringer Ingelheim : key facts 19
Table 5: Boehringer Ingelheim : key financials ($) 20
Table 6: Boehringer Ingelheim : key financials (€) 21
Table 7: Boehringer Ingelheim : key financial ratios 21
Table 8: MediGene AG: key facts 23
Table 9: MediGene AG: key financials ($) 24
Table 10: MediGene AG: key financials (€) 24
Table 11: MediGene AG: key financial ratios 25
Table 12: Merck KGaA: key facts 27
Table 13: Merck KGaA: key financials ($) 28
Table 14: Merck KGaA: key financials (€) 28
Table 15: Merck KGaA: key financial ratios 28
Table 16: Morphosys: key facts 30
Table 17: Morphosys: key financials ($) 31
Table 18: Morphosys: key financials (€) 32
Table 19: Morphosys: key financial ratios 32
Table 20: Germany biotechnology market value forecast: $ million, 2010–15 34
Table 21: Germany size of population (million), 2006–10 35
Table 22: Germany gdp (constant 2000 prices, $ billion), 2006–10 35
Table 23: Germany gdp (current prices, $ billion), 2006–10 35
Table 24: Germany inflation, 2006–10 36
Table 25: Germany consumer price index (absolute), 2006–10 36
Table 26: Germany exchange rate, 2006–10 36
LIST OF FIGURES
Figure 1: Germany biotechnology market value: $ million, 2006–10 10
Figure 2: Germany biotechnology market segmentation I:% share, by value, 2010 11
Figure 3: Germany biotechnology market segmentation II: % share, by value, 2010 12
Figure 4: Forces driving competition in the biotechnology market in Germany, 2010 13
Figure 5: Drivers of buyer power in the biotechnology market in Germany, 2010 14
Figure 6: Drivers of supplier power in the biotechnology market in Germany, 2010 15
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Germany, 2010 16
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Germany, 2010 17
Figure 9: Drivers of degree of rivalry in the biotechnology market in Germany, 2010 18
Figure 10: Boehringer Ingelheim : revenues & profitability 22
Figure 11: Boehringer Ingelheim : assets & liabilities 22
Figure 12: MediGene AG: revenues & profitability 25
Figure 13: MediGene AG: assets & liabilities 26
Figure 14: Merck KGaA: revenues & profitability 29
Figure 15: Merck KGaA: assets & liabilities 29
Figure 16: Morphosys: revenues & profitability 33
Figure 17: Morphosys: assets & liabilities 33
Figure 18: Germany biotechnology market value forecast: $ million, 2010–15 34
[Inhaltsverzeichnis ausblenden]
